The prescribing of drugs to treat children diagnosed with attention deficit hyperactivity disorder has almost doubled over a six year period.
In 1998 there were around 220,000 prescriptions in England for drugs such as methylphenidate and dexamfetamine
By 2004 this had almost doubled to 418,300 prescriptions.
The figures were published today by The National Institute for Health and Clinical Excellence (formerly the National Institute for Clinical Excellence) as it prepares to develop clinical guideline on attention deficit hyperactivity disorder for NHS professionals in England and Wales.
The institute also released today draft clinical guidelines for bipolar affective disorder which is out for consultation